Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
104.7 CHF | -10.65% | -10.65% | +12.25% |
06-19 | CARL ZEISS MEDITEC : CZM’s eye attractiveness fades | |
06-18 | CARL ZEISS MEDITEC : CZM’s eye attractiveness fades |
Evolution of the average Target Price on Carl Zeiss Meditec AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Carl Zeiss Meditec AG
alphavalue | Anas Patel |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
HAUCK AUFHÄUSER INVESTMENT BANKING | Alexander Galitsa |
DZ BANK | Thomas Maul |
GOLDMAN SACHS | Richard Felton |
JPMORGAN | Anchal Verma |
RBC | Jack Reynolds-Clark |
UBS | Graham Doyle |
BERENBERG | Sam England |
BERNSTEIN RESEARCH | Susannah Ludwig |
BANK OF AMERICA (BOFA) | Julien Ouaddour |
HAUCK AUFHÄUSER LAMPE | Alexander Galitsa |
DEUTSCHE BANK | Falko Friedrichs |
HSBC | Sezgi Oezener |
KEPLER CHEUVREUX | Oliver Reinberg |
NORDLB | Holger Fechner |
HAUCK & AUFHÄUSER | Aliaksandr Halitsa |
INDEPENDENT RESEARCH | Tobias Gottschalt |
EPS Revisions
- Stock Market
- Equities
- AFX Stock
- AFX Stock
- Consensus Carl Zeiss Meditec AG